Literature DB >> 18203712

Two distinct pathways for cyclooxygenase-2 protein degradation.

Uri R Mbonye1, Chong Yuan, Clair E Harris, Ranjinder S Sidhu, Inseok Song, Toshiya Arakawa, William L Smith.   

Abstract

Cyclooxygenases (COX-1 and COX-2) are N-glycosylated, endoplasmic reticulum-resident, integral membrane proteins that catalyze the committed step in prostanoid synthesis. COX-1 is constitutively expressed in many types of cells, whereas COX-2 is usually expressed inducibly and transiently. The control of COX-2 protein expression occurs at several levels, and overexpression of COX-2 is associated with pathologies such as colon cancer. Here we have investigated COX-2 protein degradation and demonstrate that it can occur through two independent pathways. One pathway is initiated by post-translational N-glycosylation at Asn-594. The N-glycosyl group is then processed, and the protein is translocated to the cytoplasm, where it undergoes proteasomal degradation. We provide evidence from site-directed mutagenesis that a 27-amino acid instability motif (27-IM) regulates posttranslational N-glycosylation of Asn-594. This motif begins with Glu-586 8 residues upstream of the N-glycosylation site and ends with Lys-612 near the C terminus at Leu-618. Key elements of the 27-IM include a helix involving residues Glu-586 to Ser-596 with Asn-594 near the end of this helix and residues Leu-610 and Leu-611, which are located in an apparently unstructured downstream region of the 27-IM. The last 16 residues of the 27-IM, including Leu-610 and Leu-611, appear to promote N-glycosylation of Asn-594 perhaps by causing this residue to become exposed to appropriate glycosyl transferases. A second pathway for COX-2 protein degradation is initiated by substrate-dependent suicide inactivation. Suicide-inactivated protein is then degraded. The biochemical steps have not been resolved, but substrate-dependent degradation is not inhibited by proteasome inhibitors or inhibitors of lysosomal proteases. The pathway involving the 27-IM occurs at a constant rate, whereas degradation through the substrate-dependent process is coupled to the rate of substrate turnover.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18203712     DOI: 10.1074/jbc.M710137200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  40 in total

Review 1.  Enzymes of the cyclooxygenase pathways of prostanoid biosynthesis.

Authors:  William L Smith; Yoshihiro Urade; Per-Johan Jakobsson
Journal:  Chem Rev       Date:  2011-09-27       Impact factor: 60.622

2.  Flipping the cyclooxygenase (Ptgs) genes reveals isoform-specific compensatory functions.

Authors:  Xinzhi Li; Liudmila L Mazaleuskaya; Chong Yuan; Laurel L Ballantyne; Hu Meng; William L Smith; Garret A FitzGerald; Colin D Funk
Journal:  J Lipid Res       Date:  2017-11-27       Impact factor: 5.922

3.  Interactions of 2-O-arachidonylglycerol ether and ibuprofen with the allosteric and catalytic subunits of human COX-2.

Authors:  Liang Dong; Hechang Zou; Chong Yuan; Yu H Hong; Charis L Uhlson; Robert C Murphy; William L Smith
Journal:  J Lipid Res       Date:  2016-04-08       Impact factor: 5.922

4.  Prostaglandin EP1 receptor down-regulates expression of cyclooxygenase-2 by facilitating its proteasomal degradation.

Authors:  Ariz Haddad; Galit Flint-Ashtamker; Waleed Minzel; Rapita Sood; Gilad Rimon; Liza Barki-Harrington
Journal:  J Biol Chem       Date:  2012-04-03       Impact factor: 5.157

5.  A seven-step plan for becoming a moderately rich and famous biochemist.

Authors:  William L Smith
Journal:  J Biol Chem       Date:  2019-02-08       Impact factor: 5.157

6.  Additive inhibition of colorectal cancer cell lines by aspirin and bortezomib.

Authors:  Ioannis A Voutsadakis; Anna Patrikidou; Konstantinos Tsapakidis; Aristea Karagiannaki; Eleana Hatzidaki; Nikolaos E Stathakis; Christos N Papandreou
Journal:  Int J Colorectal Dis       Date:  2010-04-16       Impact factor: 2.571

Review 7.  Cyclooxygenases: structural and functional insights.

Authors:  Carol A Rouzer; Lawrence J Marnett
Journal:  J Lipid Res       Date:  2008-10-23       Impact factor: 5.922

8.  Fatty Acid Binding to the Allosteric Subunit of Cyclooxygenase-2 Relieves a Tonic Inhibition of the Catalytic Subunit.

Authors:  Liang Dong; Chong Yuan; Benjamin J Orlando; Michael G Malkowski; William L Smith
Journal:  J Biol Chem       Date:  2016-10-18       Impact factor: 5.157

9.  Cyclooxygenase Allosterism, Fatty Acid-mediated Cross-talk between Monomers of Cyclooxygenase Homodimers.

Authors:  Chong Yuan; Ranjinder S Sidhu; Dmitry V Kuklev; Yuji Kado; Masayuki Wada; Inseok Song; William L Smith
Journal:  J Biol Chem       Date:  2009-02-12       Impact factor: 5.157

10.  Development of prostaglandin endoperoxide synthase expression in the ovine fetal central nervous system and pituitary.

Authors:  Jason A Gersting; Christine E Schaub; Charles E Wood
Journal:  Gene Expr Patterns       Date:  2009-08-23       Impact factor: 1.224

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.